Pharma expansion: Natco to acquire major stake in South Africa’s Adcock Ingram, firm to go private

Indian firm Natco Pharma is set to acquire substantial stakes in South African pharmaceutical company Adcock Ingram. This deal, valued at R4.2 billion, will transition Adcock Ingram into a privately held company. Natco and Bidvest will jointly own the firm, with Bidvest retaining majority control. Adcock Ingram shareholders have approved the proposal.